Rhumbline Advisers Acquires 6,765 Shares of CME Group Inc. (CME)

Rhumbline Advisers raised its position in shares of CME Group Inc. (NASDAQ:CME) by 1.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 646,644 shares of the financial services provider’s stock after buying an additional 6,765 shares during the period. Rhumbline Advisers owned 0.19% of CME Group worth $80,986,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Guardian Life Insurance Co. of America boosted its position in shares of CME Group by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock worth $156,000 after buying an additional 9 shares during the last quarter. Honkamp Krueger Financial Services Inc. boosted its position in shares of CME Group by 0.4% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock worth $368,000 after buying an additional 13 shares during the last quarter. Pitcairn Co. boosted its position in shares of CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock worth $386,000 after buying an additional 14 shares during the last quarter. Buffington Mohr McNeal boosted its position in shares of CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock worth $570,000 after buying an additional 15 shares during the last quarter. Finally, Summit Asset Management LLC boosted its position in shares of CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock worth $358,000 after buying an additional 16 shares during the last quarter. Institutional investors and hedge funds own 83.29% of the company’s stock.

CME Group Inc. (NASDAQ CME) opened at 124.19 on Friday. The company has a market cap of $42.21 billion, a PE ratio of 25.35 and a beta of 0.73. The stock has a 50 day moving average of $123.43 and a 200 day moving average of $120.91. CME Group Inc. has a one year low of $98.95 and a one year high of $127.96.

CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS. On average, analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 2.13%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio is currently 53.99%.

TRADEMARK VIOLATION NOTICE: This story was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.com-unik.info/2017/08/11/rhumbline-advisers-acquires-6765-shares-of-cme-group-inc-cme.html.

A number of research analysts have commented on the stock. UBS AG reiterated a “buy” rating and set a $134.00 price target (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price target on shares of CME Group in a research report on Friday, July 14th. BidaskClub cut shares of CME Group from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Finally, Deutsche Bank AG reduced their price target on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research report on Tuesday, July 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $131.63.

In other CME Group news, Director Ronald A. Pankau sold 300 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $124.78, for a total value of $37,434.00. Following the transaction, the director now owns 4,009 shares of the company’s stock, valued at approximately $500,243.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kathleen M. Cronin sold 8,125 shares of the company’s stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now directly owns 38,174 shares in the company, valued at approximately $4,861,458.90. The disclosure for this sale can be found here. In the last three months, insiders have sold 90,885 shares of company stock worth $11,217,668. Corporate insiders own 0.61% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit